文献速递慢性静脉疾病静脉血栓栓塞

大隐静脉消融治疗患者深静脉反流的发生率与意义

Incidence and Significance of Deep Venous Reflux in Patients Treated with Saphenous Vein Ablation.
PubMed 文献 · Ann Vasc Surg · 2023-01-21

回顾性分析2012年3月至2016年6月单中心362例患者共497次大隐静脉消融,术前超声深静脉反流(>1秒)发生率为20%(N=71)。深静脉反流组男性及黑人比例更高、深静脉血栓史更多,CEAP分期及症状严重程度无显著差异,但术后EHIT II-IV发生率更高(6% vs 1%,P=0.002);平均随访26个月两组疼痛与肿胀评分仍无差异。

要点

  • 大隐静脉消融患者深静脉反流(>1秒)发生率为20%(71/362例)。
  • 深静脉反流组EHIT II-IV发生率6% vs 无深静脉反流组1%(P=0.002)。
  • 深静脉反流与CEAP分期、症状严重程度及消融后临床缓解无显著关联。

核心结论

  • 本研究中20%接受大隐静脉消融的患者存在深静脉反流,在黑人男性中更常见。
  • 深静脉反流与消融后EHIT风险增加相关,但似乎不影响疾病严重程度或消融后临床缓解。
  • 作者认为需要更大规模研究以理解血栓后性与原发性深静脉反流的结局差异。

研究设计与样本

  • 回顾性审查2012年3月至2016年6月在一家三级医疗中心接受大隐静脉消融患者的电子病历。
  • 按大隐静脉消融前初始超声是否存在深静脉反流分为2组,比较患者特征与结局。
  • 进行电话调查评估长期症状缓解、弹力袜依从性及止痛药使用,并对血栓后性与原发性深静脉反流进行亚组分析。

主要发现

  • 362例患者共接受497次消融,深静脉反流(>1秒)发生率为20%(N=71)。
  • 深静脉反流组男性比例46.4% vs 无深静脉反流组32.1%(P=0.021),黑人比例21.2% vs 5.5%(P=0.0001)。
  • 深静脉反流组深静脉血栓史比例15.1% vs 无深静脉反流组7.9%(P=0.045),其他合并症无差异。
  • 两组就诊症状、CEAP分期及疼痛与肿胀数字评分量表(NRS,0-10分)严重程度无显著差异。
  • 两组大隐静脉消融临床成功率相当,但深静脉反流组EHIT II-IV发生率6% vs 无深静脉反流组1%(P=0.002)。

局限性

  • 作者认为需要更大规模研究以理解血栓后性与原发性深静脉反流的结局差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous ablation (VA) of the saphenous vein is the most common procedure performed for venous insufficiency. The incidence of concomitant deep venous reflux (DVR) in patients undergoing VA is unknown. Our hypothesis is that patients undergoing saphenous VA with concomitant DVR exhibit a higher clinical, etiology, anatomy, and pathophysiology (CEAP) stage and less relief after VA compared to patients without DVR. METHODS: Electronic medical records of patients treated with saphenous VA at a tertiary care center from March 2012 to June 2016 were reviewed. Patients were divided into 2 groups based on presence or absence of DVR on initial ultrasound (US) before saphenous VA. Patient characteristics and outcomes were compared. A telephone survey was conducted to assess long-term symptomatic relief, compliance with compression, and pain medication use. Subgroup analysis of patients with post-thrombotic versus primary DVR was performed. RESULTS: 362 patients underwent 497 ablations, and the incidence of DVR (>1 sec) was 20% (N = 71). Patients with DVR were significantly more likely to be male (46.4% vs. 32.1%, P = 0.021) and of Black race (21.2% vs. 5.5%, P = 0.0001) compared to patients without DVR. Patients with DVR were more likely to have a history of deep vein thrombosis (DVT) (15.1% vs. 7.9%, P = 0.045), but there was no difference in other comorbidities. There was no significant difference in presenting symptoms, CEAP stage, or symptom severity based on numeric rating scale (NRS) (0-10) for pain and swelling. Clinical success of saphenous VA was comparable between the 2 groups, but patients with DVR were more likely to develop endovenous heat-induced thrombosis (EHIT) II-IV (6% vs. 1%, P = 0.002). After a mean follow-up of 26 months, there was still no difference in pain or swelling scores, but patients with DVR were more likely to use compression stockings and used them more frequently. Only 11 of 71 patients with DVR had a history of DVT. Patients with post-thrombotic DVR were significantly older than patients with primary DVR (67.3 vs. 57.2, P = 0.038) and exhibited a trend toward more advanced venous disease (C4-C6: 45.4% vs. 33.3%, P = 0.439). CONCLUSIONS: In this study, 20% of patients undergoing saphenous VA demonstrated DVR, which was more common in Black men. Presence of DVR is associated with increased risk of EHIT after saphenous VA but does not seem to impact disease severity or clinical relief after ablation. Larger studies are needed to understand outcome differences between post-thrombotic and primary DVR.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Satam K, Aurshina A, Zhuo H, et al. Incidence and Significance of Deep Venous Reflux in Patients Treated with Saphenous Vein Ablation. Ann Vasc Surg. 2023. PMID: 36693564. doi:10.1016/j.avsg.2022.11.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。